A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers

Clinical trial NCT04926324 · TERMINATED

Trial details

NCT number: NCT04926324
Sponsor: University of Iowa
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Rectal Neoplasms Rectal Neoplasm Malignant

Start date: 2022-07-07
Primary completion: 2024-11-18
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.